Soluble IL-2R assay and spontaneous blastogenesis in the immunological monitoring of kidney transplant patients.
de Boccardo
G
G
Renal Transplant Program, Hospital Privado-Centro Medico de Córdoba, Argentina.
Albano
S
S
Alvarellos
T
T
Massari
P
P
Giraudo
C
C
D001379:Azathioprine / Q000627:therapeutic use; D015415:Biomarkers / Q000097:blood; D002478:Cells, Cultured; D016572:Cyclosporine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006084:Graft Rejection / Q000097:blood / Q000175:diagnosis* / Q000276:immunology; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007676:Kidney Failure, Chronic / Q000276:immunology / Q000628:therapy; D016030:Kidney Transplantation / Q000276:immunology*; D008213:Lymphocyte Activation; D008214:Lymphocytes / Q000276:immunology*; D015166:Monitoring, Immunologic; D011241:Prednisone / Q000627:therapeutic use; D015375:Receptors, Interleukin-2 / Q000032:analysis*; D006435:Renal Dialysis
D015415:Biomarkers; D007166:Immunosuppressive Agents; D015375:Receptors, Interleukin-2; D016572:Cyclosporine; D001379:Azathioprine; D011241:Prednisone